The HMG-I Oncogene Causes Highly Penetrant, Aggressive Lymphoid Malignancy in Transgenic Mice and Is Overexpressed in Human Leukemia
暂无分享,去创建一个
L. Resar | D. Huso | L. Wood | R. Bhattacharya | Yi Xu | E. Fuchs | T. Sumter | A. Tesfaye
[1] G. Chiappetta,et al. High-mobility group A1 proteins are overexpressed in human leukaemias. , 2003, The Biochemical journal.
[2] N. Harris,et al. Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.
[3] L. Resar,et al. HMG-I/Y in human breast cancer cell lines , 2002, Breast Cancer Research and Treatment.
[4] W. Isaacs,et al. High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells. , 2002, Cancer research.
[5] T. Poggio,et al. Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.
[6] S. Lomvardas,et al. Coordination of a transcriptional switch by HMGI(Y) acetylation. , 2001, Science.
[7] R. Reeves,et al. Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells , 2001, Molecular and Cellular Biology.
[8] L. Resar,et al. HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene , 2000, Molecular and Cellular Biology.
[9] L. Resar,et al. The oncogenic properties of the HMG-I gene family. , 2000, Cancer research.
[10] G. Chiappetta,et al. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] H. Dintzis,et al. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[12] U. K. Laemmli,et al. SARs are cis DNA elements of chromosome dynamics: Synthesis of a SAR repressor protein , 1995, Cell.
[13] U. K. Laemmli,et al. Metaphase chromosome structure: Bands arise from a differential folding path of the highly AT-rich scaffold , 1994, Cell.
[14] T. Maniatis,et al. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements , 1993, Cell.
[15] M. Davisson,et al. Chromosomal localization of the murine gene and two related sequences encoding high-mobility-group I and Y proteins. , 1992, Genomics.
[16] H. Pircher,et al. T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. , 1989, The EMBO journal.
[17] P. Leder,et al. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Palmiter,et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.
[19] S. Laland,et al. On the presence of two new high mobility group‐like proteins in HeLa S3 cells , 1983, FEBS letters.